A Persistent Vulvar Itch or Lesion: When to Work It Up
Vulvar itching gets a cream and a shrug. A lump gets called a cyst. A sore gets treated as a yeast infection, then treated again when it comes back. Most of the time that is fine, because most vulvar symptoms are benign. But a symptom that keeps returning after treatment is not a symptom that was treated. It is a symptom that was never explained. Drilling past the label to the actual cause is what Healz is built to do.
The stakes here are small but real. Vulvar cancer is uncommon, and it has a precursor stage that can be caught and treated before it ever becomes cancer. The trap is that the precursor and the early cancer both look like ordinary irritation. What separates them from a yeast infection is not how they look on day one. It is that they do not resolve.
Why a recurring symptom earns a second look
One round of treatment that works is reassurance. The same symptom coming back after treatment is information. It means the first label was probably wrong.
The American Cancer Society is direct about this: the most common symptom of vulvar pre-cancer, called vulvar intraepithelial neoplasia or VIN, is itching that does not go away. The ACS also notes that these skin changes are often caused by conditions that are not pre-cancerous, which is exactly why women reach for over-the-counter remedies first. That instinct is usually right. The problem is when the remedy stops working and nobody changes the plan.
Ask Healz.
One chat instead of ten apps. 1M+ rare cases checked. The root cause, not the label. Private.
For invasive vulvar cancer, the ACS says almost all women have symptoms, and lists them plainly: a bump or lump that may be red, pink, or white; skin that looks lighter, darker, red, or pink; thickening; itching, pain, or burning; bleeding or discharge unrelated to a period; and an open sore, especially one that lasts a month or more. None of these is proof of cancer. Each is far more often something benign. The one signal that cuts through the noise is persistence past treatment.
The two ways vulvar cancer starts
Vulvar cancer is not one disease with one cause. It arrives by two different routes, and they show up in two different groups of people.
The first is driven by high-risk human papillomavirus, the same virus family behind cervical and anal cancer. This path tends to affect younger women, and it moves through high-grade intraepithelial lesions (HSIL, a form of VIN) before it becomes cancer. Because it is the same virus story, an HPV history elsewhere is relevant here, which is one reason how HPV and Pap co-testing read cervical risk matters beyond the cervix.
The second path has nothing to do with HPV. It grows out of chronic vulvar skin disease, most often lichen sclerosus, and it predominantly affects older women through a lesion type called differentiated VIN. The ACS reports that about 4% of women with lichen sclerosus later develop vulvar cancer. That is a low number, but it is not zero, and it is the reason long-standing vulvar skin conditions deserve monitoring rather than a permanent tube of steroid cream and no follow-up.
Age tracks these two routes. Per the ACS, fewer than 1 in 5 vulvar cancers occur before age 50, and more than half occur after age 70. A persistent lesion in an older woman with a history of vulvar skin disease is a different conversation than the same lesion in a 30-year-old, and both deserve a look.
What a real workup looks like
The workup is not complicated. It is just often skipped.
A clinician examines the vulva and the nearby lymph nodes. Suspicious areas can be viewed up close with a magnifying instrument in a procedure called vulvoscopy, sometimes with acetic acid or a dye applied to highlight abnormal tissue. But the exam only points to where to look. The American Cancer Society is unambiguous about the next step: the only way to be sure it is cancer is to do a biopsy. That means a small tissue sample, taken with a punch or by removing the abnormal area, examined under a microscope by a pathologist.
The rule that protects you is simple. Any vulvar lesion that does not resolve gets biopsied, not re-treated on a guess. If you have had a biopsy already, the report is where the answer lives, and how to read a biopsy result walks through what the pathology actually says. VIN found on biopsy can be treated before it becomes cancer, which is the entire argument for looking early instead of prescribing again.
Who is at higher risk
Persistence is the main trigger for a workup, but a few factors raise the baseline. Per the ACS, high-risk HPV infection, smoking (which multiplies HPV risk), a weakened immune system including HIV, a prior diagnosis of VIN, and lichen sclerosus all increase the odds. None of these turns a benign itch into cancer. They shift how quickly a persistent symptom deserves attention rather than another round of cream.
How Healz reads a symptom that will not resolve
A recurring vulvar symptom is a case, not a checkbox, and Healz treats it as one. Everything sits in one place. One chat, not ten apps.
Healz is equipped with root-cause technology. That is why it does not stop at "irritation" when the irritation keeps coming back. It asks what a repeat prescription skips, cross-checks your case against more than a million rare cases, and drills past the label to the cause underneath, whether that is lichen sclerosus, a high-risk HPV lesion, or something benign that simply needs a different treatment.
Frontier AI works the whole picture at once. Upload the exam notes, the swab results, and a biopsy report if you have one, and Healz reads them together instead of one page at a time. A cancer ai that only pattern-matches a generic article is not the same as one that reads your actual results in context.
Healz has memory that holds every result you upload and connects them over time. An itch you mentioned six months ago is still on the record when a sore shows up now, so the pattern is visible instead of lost between visits.
That is the difference between a search engine and a real second opinion: using ai for cancer questions only helps if it reads your actual case, not a template. When you want a human in the loop, you can bring a board-certified doctor into the same chat for a second opinion.
Frequently asked questions
- Can a yeast infection that keeps coming back be something else?
Often, yes. Recurrent vulvar itching that does not clear with treatment can be lichen sclerosus, a skin condition, an allergic reaction, or in a small number of cases vulvar pre-cancer (VIN). Per the American Cancer Society, itching that does not go away is the most common symptom of VIN. The point is not to panic but to stop re-treating and get the lesion examined.
- Is vulvar itching a sign of cancer?
Usually not. The American Cancer Society notes that vulvar itching and skin changes are far more often caused by non-cancerous conditions. Itching becomes a reason to work things up when it persists past treatment, or comes with a lump, a color change, or a sore that will not heal, especially a sore lasting a month or more.
- Does vulvar cancer need a biopsy to diagnose?
Yes. The American Cancer Society states that the only way to be sure a vulvar change is cancer is to do a biopsy. An exam or vulvoscopy can point to a suspicious area, but a tissue sample examined by a pathologist is what confirms whether it is cancer, pre-cancer, or benign.
- At what age is vulvar cancer most common?
It skews older. Per the American Cancer Society, fewer than 1 in 5 vulvar cancers occur before age 50, and more than half occur after age 70. The HPV-driven form tends to appear in younger women, while the lichen sclerosus form appears mostly in older women.
Most vulvar symptoms are benign, and most of the time the cream is the right answer. The symptom that matters is the one that comes back after treatment, because a symptom that was treated and returned was never actually explained. Healz was built to keep asking why, until the itch has a cause instead of just another prescription.
Written by Healz Team · Filed under Health Insights